Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the

GOSS

Here’s How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years

By Benzinga Insights

July 25, 2:30 PM

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 11.67% on an annualized…

WST

Jim Cramer Tweets ‘I like Costco here after the Walmart knockdown’

Related Posts

Piper Sandler Maintains Neutral on Arista Networks, Raises Price Target to $125

Rubicon Technology Says On Oct. 14, 2022 Co. Received Notifications From Nasdaq That It Was No Longer In Compliance With Various Independent Director Requirements

Gossamer Bio Q4 EPS $(0.59) Beats $(0.62) Estimate

Here’s How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years